查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1279892

2023-2030年全球慢性病管理治疗和设备技术市场规模研究和预测，按疾病、按疗法、按设备和区域分析

Global Chronic Disease Management Therapeutics and Device Technologies Market Size study & Forecast, by Disease by Therapy, by Device and Regional Analysis, 2023-2030
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

全球慢性病管理治疗剂和设备技术市场在2022年的价值约为203.5亿美元，预计在2023-2030年的预测期间将以超过1.5%的健康增长率增长。全球慢性病管理治疗和设备技术市场可以被定义为用于治疗和管理慢性病的产品和服务市场，如糖尿病、心血管疾病、癌症、呼吸系统疾病和其他。这包括药品、医疗设备和其他医疗技术，旨在通过管理与慢性病相关的症状和并发症来改善病人的治疗效果和生活质量。全球慢性病管理疗法和设备技术市场的驱动因素是慢性病发病率的增长，老年人口的增长和医疗支出的增加。此外，对创新疗法的需求增加和医疗技术的进步正在为2023-2030年预测期内的市场创造有利可图的增长机会。

全球疾病负担研究估计，在2020年，全球有17亿人至少有一种慢性病，4.15亿人有多种慢性病。全球慢性病的负担正在增加，糖尿病、心血管疾病、癌症和呼吸系统疾病等疾病影响着全世界越来越多的人。这正在推动对新的和有效的治疗和管理策略的需求。例如，在2021年，国际糖尿病联合会（IDF）报告说，全球成年人的糖尿病发病率已从2019年的9.3%上升到10.5%。这意味着全世界估计有4.63亿成年人患有糖尿病。同样，根据美国癌症协会的数据，到2040年，全球癌症负担预计将从2020年的估计1930万新病例上升到每年2950万新病例。这意味着在短短20年内增加了50%以上。然而，在2023-2030年的预测期内，慢性病管理疗法和设备技术的高成本抑制了市场增长。

全球慢性病管理治疗和设备技术市场研究考虑的主要地区包括亚太、北美、欧洲、拉美和中东及非洲。北美是慢性病管理治疗剂和设备技术的主导市场，占全球市场的重要份额。该地区强大的医疗基础设施、高额的医疗支出和有利的报销政策正在推动市场增长。在未来几年，亚太地区是慢性病管理疗法和设备技术市场中增长最快的地区。推动市场增长的因素包括人口增长、医疗支出上升和慢性病发病率上升。

该研究的目的是确定近年来不同领域和国家的市场规模，并对未来几年的价值进行预测。该报告旨在将研究涉及的国家内的行业的定性和定量方面都纳入其中。

该报告还提供了关于关键方面的详细信息，如驱动因素和挑战，这将确定市场的未来增长。此外，它还纳入了微观市场的潜在机会，供利益相关者投资，以及对竞争格局和主要参与者的疾病提供的详细分析。.

目录

第一章：执行摘要

  • 市场简介
  • 2020-2030年全球和细分市场的估计和预测
    • 2020-2030年慢性病管理治疗和设备技术市场，按地区划分
    • 2020-2030年，慢性病管理治疗和设备技术市场，按疾病分类
    • 2020-2030年慢性病管理治疗和设备技术市场，按疗法划分
    • 2020-2030年慢性病管理治疗和设备技术市场，按设备划分
  • 主要趋势
  • 估算方法
  • 研究假设

第二章：全球慢性病管理治疗学和设备技术市场的定义和范围

  • 本研究的目的
  • 市场定义和范围
    • 行业演变
    • 研究的范围
  • 研究考虑的年份
  • 货币转换率

第三章：全球慢性病管理治疗学和设备技术市场动态

  • 慢性病管理治疗药物和设备技术市场影响分析（2020-2030）。
    • 市场驱动力
      • 慢性病的发病率不断提高
      • 不断增长的老年人口
      • 不断增长的医疗开支
    • 市场挑战
      • 慢性病管理疗法和设备技术的高成本
    • 市场机会
      • 对创新疗法的需求不断增加
      • 医疗技术的进步

第四章：全球慢性病管理治疗药物和设备技术市场行业分析

  • 波特的五力模型
    • 供应商的讨价还价能力
    • 买方的讨价还价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争性的竞争
  • 波特五力影响分析
  • PEST分析
    • 政治
    • 经济
    • 社会
    • 技术
    • 环境
    • 法律问题
  • 最佳投资机会
  • 最佳策略
  • COVID-19影响分析
  • 颠覆性趋势
  • 行业专家的观点
  • 分析师建议与结论

第五章：全球慢性病管理疗法和设备技术市场，按疾病分类

  • 市场简介
  • 全球慢性病管理治疗和设备技术市场，按疾病，性能-潜力分析
  • 2020-2030年全球慢性病管理治疗剂和设备技术市场按疾病的估计和预测
  • 慢性病管理治疗剂和设备技术市场，細項分析
    • 心血管疾病(CVD)
    • 糖尿病
    • 癌症
    • 慢性呼吸系统疾病
    • 慢性肾脏疾病
    • 神经系统疾病
    • 其他（如自身免疫性疾病、胃肠道疾病，以及许多）。

第六章：全球慢性病管理治疗药物和设备技术市场，按疗法分类

  • 市场简介
  • 全球慢性病管理治疗和设备技术市场，按治疗方法，性能-潜力分析
  • 2020-2030年全球慢性病管理治疗学和设备技术市场按疗法的估计和预测
  • 慢性病管理治疗学和设备技术市场，細項分析
    • 药物治疗
    • 康复治疗
    • 行为治疗
    • 其他（如基因治疗、干细胞治疗和许多）。

第7章 ：全球慢性病管理治疗方法和设备技术市场，按设备划分

  • 市场简介
  • 全球慢性病管理治疗剂和设备技术市场，按设备，性能-潜力分析
  • 2020-2030年全球慢性病管理治疗剂和设备技术市场按设备的估计和预测
  • 慢性病管理治疗剂和设备技术市场，細項分析
    • 血糖监测设备
    • 血压监测仪
    • 心脏监测仪
    • 呼吸系统治疗设备
    • 肾脏透析机
    • 神经刺激设备
    • 其他（如胰岛素泵、持续血糖监测设备等）。

第八章：全球慢性病管理治疗药物和设备技术市场，区域分析

  • 最领先的国家
  • 顶级新兴国家
  • 慢性病管理治疗药物和设备技术市场，区域市场简介
  • 北美洲
    • 美国
      • 2020-2030年疾病细分的估计和预测
      • 2020-2030年，治疗的细分估计和预测
      • 2020-2030年设备分类估计和预测
    • 加拿大
  • 欧洲慢性病管理治疗方法和设备技术市场简介
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 亚太地区慢性病管理治疗药物和设备技术市场简介
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 亚太其他地区
  • 拉丁美洲慢性病管理治疗药物和设备技术市场简介
    • 巴西
    • 墨西哥
  • 中东和非洲
    • 沙特阿拉伯
    • 南非
    • 中东和非洲其他地区

第九章：竞争情报

  • 主要公司SWOT分析
    • 公司1
    • 公司二
    • 公司3
  • 顶级市场战略
  • 公司简介
    • Medtronic plc
      • 关键信息
      • 概况
      • 财务（取决于数据的可用性）
      • 产品摘要
      • 近期发展情况
    • Novo Nordisk A/S
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd
    • GlaxoSmithKline plc
    • Johnson & Johnson Consumer Incd
    • Sanofi S.A.
    • Dexcom, Inc.
    • AstraZeneca plc
    • Becton, Dickinson and Company (BD)

第十章 ：研究过程

  • 研究过程
    • 资料探勘
    • 数据分析
    • 市场评估
    • 验证
    • 出版
  • 研究属性
  • 研究假设

Global Chronic Disease Management Therapeutics and Device Technologies Market is valued at approximately USD 20.35 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 1.5% over the forecast period 2023-2030. The global chronic disease management therapeutics and device technologies market can be defined as the market for products and services that are used in the treatment and management of chronic diseases, such as diabetes, cardiovascular disease, cancer, respiratory disease, and others. This includes pharmaceuticals, medical devices, and other healthcare technologies that are designed to improve patient outcomes and quality of life by managing the symptoms and complications associated with chronic diseases. The driving factors for the Global Chronic Disease Management Therapeutics and Device Technologies Market are the growing prevalence of chronic diseases, growing geriatric population and rising healthcare expenditure. Moreover, increasing demand for innovative therapies and advances in medical technology is creating lucrative growth opportunities for the market over the forecast period 2023-2030.

The Global Burden of Disease study estimated that in 2020, 1.7 billion people worldwide had at least one chronic disease, and 415 million had multiple chronic diseases. The global burden of chronic diseases is increasing, with conditions such as diabetes, cardiovascular disease, cancer, and respiratory disease affecting a growing number of people worldwide. This is driving demand for new and effective treatments and management strategies. For instance, in 2021, the International Diabetes Federation (IDF) reported that the global prevalence of diabetes had risen to 10.5% among adults, up from 9.3% in 2019. This represents an estimated 463 million adults living with diabetes worldwide. Similarly, according to the American Cancer Society, the global cancer burden is expected to rise to 29.5 million new cases annually by 2040, up from an estimated 19.3 million new cases in 2020. This represents an increase of more than 50% in just 20 years. However, the high cost of Chronic Disease Management Therapeutics and Device Technologies stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Chronic Disease Management Therapeutics and Device Technologies Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is the dominating market for chronic disease management therapeutics and device technologies, accounting for a significant share of the global market. The region's strong healthcare infrastructure, high healthcare spending, and favorable reimbursement policies are driving the market growth. The Asia Pacific region is the fastest growing region in the chronic disease management therapeutics and device technologies market in the coming years. Factors driving market growth include the growing population, rising healthcare spending, and increasing prevalence of chronic diseases.

Major market players included in this report are:

  • Medtronic plc
  • Novo Nordisk A/S
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Johnson & Johnson Consumer Inc.
  • Sanofi S.A.
  • Dexcom, Inc.
  • AstraZeneca plc
  • Becton, Dickinson and Company (BD)

Recent Developments in the Market:

  • In September 2020, Medtronic launched its MiniMed 770G insulin pump system, which uses advanced algorithms to automatically adjust insulin delivery to help people with diabetes better manage their blood sugar levels.
  • In June 2020, Abbott received FDA clearance for its FreeStyle Libre 2 continuous glucose monitoring system, which allows people with diabetes to monitor their glucose levels without the need for fingerstick.

Global Chronic Disease Management Therapeutics and Device Technologies Market Report Scope:

  • Historical Data: - 2020 - 2021
  • Base Year for Estimation: - 2022
  • Forecast period: - 2023-2030
  • Report Coverage: - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: - Disease, Therapy, Device, Region
  • Regional Scope: - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Disease offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Disease:

  • Cardiovascular diseases (CVD)
  • Diabetes
  • Cancer
  • Chronic respiratory diseases
  • Chronic kidney diseases
  • Neurological disorders
  • Others (such as autoimmune diseases, gastrointestinal disorders, and many)

By Therapy:

  • Medications
  • Rehabilitation therapy
  • Behavioral therapy
  • Others (such as gene therapy, stem cell therapy, and many)

By Device:

  • Blood glucose monitoring devices
  • Blood pressure monitors
  • Cardiac monitors
  • Respiratory therapy devices
  • Kidney dialysis machines
  • Neurostimulation devices
  • Others (such as insulin pumps, continuous glucose monitoring devices, and many)

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Chronic Disease Management Therapeutics and Device Technologies Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Chronic Disease Management Therapeutics and Device Technologies Market, by Disease, 2020-2030 (USD Billion)
    • 1.2.3. Chronic Disease Management Therapeutics and Device Technologies Market, by Therapy, 2020-2030 (USD Billion)
    • 1.2.4. Chronic Disease Management Therapeutics and Device Technologies Market, by Device, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Chronic Disease Management Therapeutics and Device Technologies Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Chronic Disease Management Therapeutics and Device Technologies Market Dynamics

  • 3.1. Chronic Disease Management Therapeutics and Device Technologies Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Growing prevalence of chronic diseases
      • 3.1.1.2. Growing Geriatric Population
      • 3.1.1.3. Rising healthcare expenditure
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Chronic Disease Management Therapeutics and Device Technologies
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing demand for innovative therapies
      • 3.1.3.2. Advances in medical technology

Chapter 4. Global Chronic Disease Management Therapeutics and Device Technologies Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Chronic Disease Management Therapeutics and Device Technologies Market, by Disease

  • 5.1. Market Snapshot
  • 5.2. Global Chronic Disease Management Therapeutics and Device Technologies Market by Disease, Performance - Potential Analysis
  • 5.3. Global Chronic Disease Management Therapeutics and Device Technologies Market Estimates & Forecasts by Disease 2020-2030 (USD Billion)
  • 5.4. Chronic Disease Management Therapeutics and Device Technologies Market, Sub Segment Analysis
    • 5.4.1. Cardiovascular diseases (CVD)
    • 5.4.2. Diabetes
    • 5.4.3. Cancer
    • 5.4.4. Chronic respiratory diseases
    • 5.4.5. Chronic kidney diseases
    • 5.4.6. Neurological disorders
    • 5.4.7. Others (such as autoimmune diseases, gastrointestinal disorders, and many)

Chapter 6. Global Chronic Disease Management Therapeutics and Device Technologies Market, by Therapy

  • 6.1. Market Snapshot
  • 6.2. Global Chronic Disease Management Therapeutics and Device Technologies Market by Therapy, Performance - Potential Analysis
  • 6.3. Global Chronic Disease Management Therapeutics and Device Technologies Market Estimates & Forecasts by Therapy 2020-2030 (USD Billion)
  • 6.4. Chronic Disease Management Therapeutics and Device Technologies Market, Sub Segment Analysis
    • 6.4.1. Medications
    • 6.4.2. Rehabilitation therapy
    • 6.4.3. Behavioral therapy
    • 6.4.4. Others (such as gene therapy, stem cell therapy, and many)

Chapter 7. Global Chronic Disease Management Therapeutics and Device Technologies Market, by Device

  • 7.1. Market Snapshot
  • 7.2. Global Chronic Disease Management Therapeutics and Device Technologies Market by Device, Performance - Potential Analysis
  • 7.3. Global Chronic Disease Management Therapeutics and Device Technologies Market Estimates & Forecasts by Device 2020-2030 (USD Billion)
  • 7.4. Chronic Disease Management Therapeutics and Device Technologies Market, Sub Segment Analysis
    • 7.4.1. Blood glucose monitoring devices
    • 7.4.2. Blood pressure monitors
    • 7.4.3. Cardiac monitors
    • 7.4.4. Respiratory therapy devices
    • 7.4.5. Kidney dialysis machines
    • 7.4.6. Neurostimulation devices
    • 7.4.7. Others (such as insulin pumps, continuous glucose monitoring devices, and many)

Chapter 8. Global Chronic Disease Management Therapeutics and Device Technologies Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Chronic Disease Management Therapeutics and Device Technologies Market, Regional Market Snapshot
  • 8.4. North America Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.4.1. U.S. Chronic Disease Management Therapeutics and Device Technologies Market
      • 8.4.1.1. Disease breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Therapy breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. Device breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Chronic Disease Management Therapeutics and Device Technologies Market
  • 8.5. Europe Chronic Disease Management Therapeutics and Device Technologies Market Snapshot
    • 8.5.1. U.K. Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.5.2. Germany Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.5.3. France Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.5.4. Spain Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.5.5. Italy Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.5.6. Rest of Europe Chronic Disease Management Therapeutics and Device Technologies Market
  • 8.6. Asia-Pacific Chronic Disease Management Therapeutics and Device Technologies Market Snapshot
    • 8.6.1. China Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.6.2. India Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.6.3. Japan Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.6.4. Australia Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.6.5. South Korea Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.6.6. Rest of Asia Pacific Chronic Disease Management Therapeutics and Device Technologies Market
  • 8.7. Latin America Chronic Disease Management Therapeutics and Device Technologies Market Snapshot
    • 8.7.1. Brazil Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.7.2. Mexico Chronic Disease Management Therapeutics and Device Technologies Market
  • 8.8. Middle East & Africa Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.8.1. Saudi Arabia Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.8.2. South Africa Chronic Disease Management Therapeutics and Device Technologies Market
    • 8.8.3. Rest of Middle East & Africa Chronic Disease Management Therapeutics and Device Technologies Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Medtronic plc
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Novo Nordisk A/S
    • 9.3.3. Abbott Laboratories
    • 9.3.4. F. Hoffmann-La Roche Ltd
    • 9.3.5. GlaxoSmithKline plc
    • 9.3.6. Johnson & Johnson Consumer Incd
    • 9.3.7. Sanofi S.A.
    • 9.3.8. Dexcom, Inc.
    • 9.3.9. AstraZeneca plc
    • 9.3.10. Becton, Dickinson and Company (BD)

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Chronic Disease Management Therapeutics and Device Technologies Market, report scope
  • TABLE 2. Global Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by Disease 2020-2030 (USD Billion)
  • TABLE 4. Global Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by Therapy 2020-2030 (USD Billion)
  • TABLE 5. Global Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by Device 2020-2030 (USD Billion)
  • TABLE 6. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Chronic Disease Management Therapeutics and Device Technologies Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Chronic Disease Management Therapeutics and Device Technologies Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Chronic Disease Management Therapeutics and Device Technologies Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Chronic Disease Management Therapeutics and Device Technologies Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Chronic Disease Management Therapeutics and Device Technologies Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Chronic Disease Management Therapeutics and Device Technologies Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Chronic Disease Management Therapeutics and Device Technologies Market
  • TABLE 71. List of primary sources, used in the study of global Chronic Disease Management Therapeutics and Device Technologies Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Chronic Disease Management Therapeutics and Device Technologies Market, research methodology
  • FIG 2. Global Chronic Disease Management Therapeutics and Device Technologies Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Chronic Disease Management Therapeutics and Device Technologies Market, key trends 2022
  • FIG 5. Global Chronic Disease Management Therapeutics and Device Technologies Market, growth prospects 2023-2030
  • FIG 6. Global Chronic Disease Management Therapeutics and Device Technologies Market, porters 5 force model
  • FIG 7. Global Chronic Disease Management Therapeutics and Device Technologies Market, pest analysis
  • FIG 8. Global Chronic Disease Management Therapeutics and Device Technologies Market, value chain analysis
  • FIG 9. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Chronic Disease Management Therapeutics and Device Technologies Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Chronic Disease Management Therapeutics and Device Technologies Market, regional snapshot 2020 & 2030
  • FIG 15. North America Chronic Disease Management Therapeutics and Device Technologies Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Chronic Disease Management Therapeutics and Device Technologies Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Chronic Disease Management Therapeutics and Device Technologies Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Chronic Disease Management Therapeutics and Device Technologies Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Chronic Disease Management Therapeutics and Device Technologies Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable